View Post

Rare Patient Voice: Diffuse large B-cell lymphoma Patients & Caregivers

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Study Details: 60 min Web-Assisted Phone Interview Compensation $100 Please sign up at the link below for more information or to see if you qualify. http://letlife.in/rare-patient-voice Why Sign up with Rare Patient Voice? Who knows better than you about your journey and experiences?  We connect you with researchers who are developing products and services which can help you and others with …

View Post

Greenwich LifeSciences Presents Immune Response Phase IIb Poster

In Clinical Studies News by Barbara Jacoby

From: businesswire.com Published Today at AACR 2021, Showing Peak Immunity after 6 Months of GP2 Treatment, Resulting in 100% Disease Free Survival from Recurring Breast Cancer Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today presented a …

View Post

Treatment and outlook for stage 2 breast cancer

In In The News by Barbara Jacoby

Source: healthline.com From: medicalnewstoday.com People with stage 2 breast cancer have cancer cells in their breast tissue, nearby lymph nodes, or both. Stage 2 breast cancer is an early stage of breast cancer in which the cancer has not spread beyond the breast tissue or surrounding lymph nodes. Cancer stages describe the extent to which the cancer has spread and …

View Post

Rare Patient Voice: Prostate Cancer Patients

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Study Details: 60 min Web-Assisted Phone Interview plus 5 min of homework Compensation $120 Please sign up at the link below for more information or to see if you qualify. http://letlife.in/rare-patient-voice Why Sign up with Rare Patient Voice? Who knows better than you about your journey and experiences?  We connect you with researchers who are developing products and services which can help you …

View Post

Breakthrough Immunotherapy Earns First Regulatory Approval for Triple Negative Breast Cancer

In Clinical Studies News by Barbara Jacoby

From: businesswire.com Immunopheresis™ therapy holds great promise for avoiding serious drawbacks of existing pharmaceuticals and improving patients’ quality of life Immunicom, Inc., a global biotechnology company pioneering novel “subtractive” immunotherapies, today announced that the Immunopheresis™ LW-02 blood-filtering column, its leading immuno-oncology product with FDA Breakthrough Device status, has received regulatory clearance (CE Mark certification) in Europe for use in adults …

View Post

Trodelvy: Magic bullet for triple-negative breast cancer

In In The News by Barbara Jacoby

By: Ivanhoe Newswire From: winknews.com About 15 percent of all women diagnosed with breast cancer have triple-negative breast cancer, meaning drugs that target estrogen, progesterone, and HER-2 protein—won’t work. In the past, if the cancer returned, patients have had very few options. More on a newly approved drug that is stopping the cancer in its tracks. Jane Ellen Keenan is …

View Post

Rare Patient Voice: Acute Myeloid Leukemia Patients

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Study Details: 90 min Web-Assisted Phone Interview Compensation $200 Please sign up at the link below for more information or to see if you qualify. http://letlife.in/rare-patient-voice Why Sign up with Rare Patient Voice? Who knows better than you about your journey and experiences?  We connect you with researchers who are developing products and services which can help you and others …

View Post

Surgery Boosts Survival in De Novo Metastatic Breast Cancer

In Clinical Studies News by Barbara Jacoby

By: Christina Bennett, MS From: cancertherapyadvisor.com Locoregional treatment was found to improve survival for patients with de novo stage IV breast cancer and bone-only metastasis, according to the results of a multicenter registry study reported at the 17th St. Gallen International Breast Cancer Conference 2021. BOMET MF14-01 (ClinicalTrials.gov Identifier: NCT02125630) included 505 patients with de novo stage IV breast cancer …

View Post

Amazon Care and privacy: A host of unknowns

In In The News by Barbara Jacoby

By: Matt Fisher From: medcitynews.com If HIPAA does not apply to Amazon Care, then absent another privacy regulation applying, avoiding exploitation of the data relies on the good faith of the entity operating the service. The recent announcement by Amazon concerning a national launch of its telehealth offering, Amazon Care, is generating a significant amount of buzz and speculation within …